Increased Oral Bioavailability of Itraconazole and Its Active Metabolite, 7-Hydroxyitraconazole, When Coadministered With a Vitamin C Beverage in Healthy Participants
2010; Wiley; Volume: 51; Issue: 3 Linguagem: Inglês
10.1177/0091270010365557
ISSN1552-4604
AutoresSoo Kyung Bae, Soo‐Jin Park, Eon‐Jeong Shim, Ji-Hyun Mun, Eun‐Young Kim, Jae‐Gook Shin, Ji‐Hong Shon,
Tópico(s)Pharmaceutical Practices and Patient Outcomes
ResumoThe Journal of Clinical PharmacologyVolume 51, Issue 3 p. 444-451 Increased Oral Bioavailability of Itraconazole and Its Active Metabolite, 7-Hydroxyitraconazole, When Coadministered With a Vitamin C Beverage in Healthy Participants Dr Soo Kyung Bae PhD, Dr Soo Kyung Bae PhD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South Korea Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, South KoreaSearch for more papers by this authorDr Soo-Jin Park PhD, Dr Soo-Jin Park PhD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South KoreaSearch for more papers by this authorDr Eon-Jeong Shim MD, Dr Eon-Jeong Shim MD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South KoreaSearch for more papers by this authorMs Ji-Hyun Mun BS, Ms Ji-Hyun Mun BS Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South KoreaSearch for more papers by this authorDr Eun-Young Kim MD, PhD, Dr Eun-Young Kim MD, PhD Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, South KoreaSearch for more papers by this authorDr Jae-Gook Shin MD, PhD, Dr Jae-Gook Shin MD, PhD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South Korea Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, South KoreaSearch for more papers by this authorDr Ji-Hong Shon MD, PhD, Corresponding Author Dr Ji-Hong Shon MD, PhD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South Korea Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, South Korea Address for correspondence: Ji-Hong Shon, MD, PhD, Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, 633-165, Gaegum-Dong, Busanjin-Gu, Busan, 614-735, South Korea; e-mail: phshon@inje.ac.kr.Search for more papers by this author Dr Soo Kyung Bae PhD, Dr Soo Kyung Bae PhD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South Korea Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, South KoreaSearch for more papers by this authorDr Soo-Jin Park PhD, Dr Soo-Jin Park PhD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South KoreaSearch for more papers by this authorDr Eon-Jeong Shim MD, Dr Eon-Jeong Shim MD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South KoreaSearch for more papers by this authorMs Ji-Hyun Mun BS, Ms Ji-Hyun Mun BS Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South KoreaSearch for more papers by this authorDr Eun-Young Kim MD, PhD, Dr Eun-Young Kim MD, PhD Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, South KoreaSearch for more papers by this authorDr Jae-Gook Shin MD, PhD, Dr Jae-Gook Shin MD, PhD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South Korea Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, South KoreaSearch for more papers by this authorDr Ji-Hong Shon MD, PhD, Corresponding Author Dr Ji-Hong Shon MD, PhD Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, South Korea Department of Clinical Pharmacology and Clinical Trial Center, Inje University Busan Paik Hospital, Busan, South Korea Address for correspondence: Ji-Hong Shon, MD, PhD, Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, 633-165, Gaegum-Dong, Busanjin-Gu, Busan, 614-735, South Korea; e-mail: phshon@inje.ac.kr.Search for more papers by this author First published: 07 March 2013 https://doi.org/10.1177/0091270010365557Citations: 19Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume51, Issue3March 2011Pages 444-451 RelatedInformation
Referência(s)